2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the treatment for patients with HPV-associated head and neck cancer.
Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the treatment for patients with HPV-associated head and neck cancer.
Many cases of head and neck cancer have become associated with HPV, explains Siegel. The implications of high-dose radiation are more consequential since the patients are younger.
Instead of using traditional chemotherapy and radiation regimens, standard doses of chemotherapy drugs have shown HPV-associated cancers shrink quicker, states Siegel.
Related Content: